We are live on
!
Find out more
AAM
Azzad Asset Management Portfolio holdings
AUM
$1.13B
1-Year Est. Return
38.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.49%
1 Year Est. Return
+38.47%
3 Year Est. Return
+100.53%
5 Year Est. Return
+132.43%
10 Year Est. Return
+597.52%
AUM
$745M
AUM Growth
+$68.8M
(+10%)
Cap. Flow
+$6.41M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
15.77%
Holding
342
New
18
Increased
160
Reduced
132
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Criteo S.A. Ordinary Shares
CRTO
|
+$2.63M |
| 2 |
Canadian Natural Resources
CNQ
|
+$2.56M |
| 3 |
Autodesk
ADSK
|
+$2.3M |
| 4 |
Canadian National Railway
CNI
|
+$2.09M |
| 5 |
AstraZeneca
AZN
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gentex
GNTX
|
+$2.68M |
| 2 |
Illinois Tool Works
ITW
|
+$2.32M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$2.22M |
| 4 |
Gartner
IT
|
+$1.98M |
| 5 |
Amgen
AMGN
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Healthcare | 14.79% |
| 3 | Industrials | 11.79% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Consumer Staples | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
CBAK Energy Technology Ltd
CBAT
$44.3M
| $111K | 0.02% |
71,451
| – | – |
|
|
SSKN
327
DELISTED
Strata Skin Sciences
SSKN
| $33.7K | ﹤0.01% |
2,300
+570
| +33% | +$9.46K |
|
|
FABC
328
Fabric.AI Inc
FABC
$18M
| $28.8K | ﹤0.01% |
140
-47
| -25% | -$15.1K |
|
329
BorgWarner
BWA
$13.9B
| – | – |
-39,581
| Closed | -$1.51M |
|
330
Cenntro
CENN
$8.23M
| – | – |
-10
| Closed | -$61.5K |
|
|
331
Canadian Pacific Kansas City
CP
$80.3B
| – | – |
-34,191
| Closed | -$2.22M |
|
332
Amdocs
DOX
$5.93B
| – | – |
-3,980
| Closed | -$301K |
|
|
333
Gentex
GNTX
$5.13B
| – | – |
-81,349
| Closed | -$2.68M |
|
334
HubSpot
HUBS
$12.5B
| – | – |
-337
| Closed | -$228K |
|
|
335
Gartner
IT
$12.7B
| – | – |
-6,506
| Closed | -$1.98M |
|
336
Lamb Weston
LW
$7.32B
| – | – |
-13,796
| Closed | -$847K |
|
337
Moderna
MRNA
$23B
| – | – |
-1,789
| Closed | -$689K |
|
338
Philips
PHG
$25.8B
| – | – |
-31,013
| Closed | -$1.14M |
|
339
iShares Silver Trust
SLV
$30.1B
| – | – |
-10,400
| Closed | -$213K |
|
340
10x Genomics
TXG
$6.2B
| – | – |
-4,666
| Closed | -$679K |
|
341
Zillow
Z
$8.3B
| – | – |
-2,458
| Closed | -$217K |
|
|
COR
342
DELISTED
Coresite Realty Corporation
COR
| – | – |
-9,830
| Closed | -$1.36M |
|
Similar funds
PL
DFCM
AT
WM
OHIF
HMCP
EC
ACM
Azzad Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Azzad Asset Management held 342 positions worth $745M, up 10% from $677M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Azzad Asset Management's Q4 2021 filing shows 18 new, 160 increased, 132 reduced and 14 closed positions. Its largest new stake was Criteo S.A. Ordinary Shares: 68,415 shares worth $2.66M. The largest sale was Gentex, an estimated $2.68M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Azzad Asset Management's largest Q4 2021 buy was Criteo S.A. Ordinary Shares: 68,415 shares worth $2.66M.
- Azzad Asset Management added most to AstraZeneca in Q4 2021, an estimated $1.79M increase.
- Azzad Asset Management's biggest Q4 2021 reduction was Illinois Tool Works, cutting an estimated $2.32M.
- Azzad Asset Management fully exited Gentex in Q4 2021, selling an estimated $2.68M.
- Azzad Asset Management's ten largest holdings make up 16% of its $745M portfolio in Q4 2021.
- Azzad Asset Management opened 18 new positions and closed 14 in Q4 2021.
- Azzad Asset Management's portfolio value rose 10% quarter-over-quarter to $745M.
Based on Azzad Asset Management's 13F filing for Q4 2021, filed 1 Apr 2024.